Progyny, Inc. (PGNY) Guidance & Earnings Results
On 2026-01-12 Progyny, Inc. raised guidance: "Q4 and FY2025 results slightly above prior…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PGNYProgyny, Inc.Follow PGNY — free
—
Price chart with a free account
- Market cap
- 2.2B
- P/E TTM
- 31.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 12 Jan 26 | Raised | Q4 and FY2025 results slightly above prior guidance |
| 6 Nov 25 | Raised | Full year guidance raised · full year |
| 7 Aug 25 | Raised | FY2025 revenue raised to $1.235-1.270B from prior range; adjusted EBITDA $205.5-214.5M; Q3 2025 revenue $290-305M; adjusted EBITDA $45-49M. · full year |
Progyny, Inc. — questions
- What guidance did Progyny, Inc. give?
- On 2026-01-12: "Q4 and FY2025 results slightly above prior guidance"
- When does Progyny, Inc. report earnings?
- Progyny, Inc.'s next earnings report is expected on 2026-11-04.
Every figure on this page comes from Progyny, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.